{
    "id": 19788,
    "fullName": "PPM1D over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PPM1D over exp indicates an over expression of the Ppm1d protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 8493,
        "geneSymbol": "PPM1D",
        "terms": [
            "PPM1D",
            "IDDGIP",
            "JDVS",
            "PP2C-DELTA",
            "WIP1"
        ]
    },
    "variant": "over exp",
    "createDate": "03/15/2016",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5264,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CCT007093 inhibited proliferation of medulloblastoma cell lines overexpressing Ppm1d in culture (PMID: 22379189).",
            "molecularProfile": {
                "id": 20201,
                "profileName": "PPM1D over exp"
            },
            "therapy": {
                "id": 3740,
                "therapyName": "CCT007093",
                "synonyms": null
            },
            "indication": {
                "id": 50902,
                "name": "medulloblastoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4974,
                    "pubMedId": 22379189,
                    "title": "HDM2 promotes WIP1-mediated medulloblastoma growth.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22379189"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5273,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CCT007093 and Taxol (paclitaxel) worked synergistically to inhibit growth of breast cancer cell lines over expressing Ppm1d in culture (PMID: 20576088).",
            "molecularProfile": {
                "id": 20201,
                "profileName": "PPM1D over exp"
            },
            "therapy": {
                "id": 3807,
                "therapyName": "CCT007093 + Paclitaxel",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4977,
                    "pubMedId": 20576088,
                    "title": "RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20576088"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5271,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CCT007093 and Nutlin-3 combination treatment demonstrated enhanced growth inhibition in medulloblastoma cell lines over expressing Ppm1d comparing to single agent treatment in culture (PMID: 22379189).",
            "molecularProfile": {
                "id": 20201,
                "profileName": "PPM1D over exp"
            },
            "therapy": {
                "id": 3806,
                "therapyName": "CCT007093 + Nutlin-3",
                "synonyms": null
            },
            "indication": {
                "id": 50902,
                "name": "medulloblastoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4974,
                    "pubMedId": 22379189,
                    "title": "HDM2 promotes WIP1-mediated medulloblastoma growth.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22379189"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5262,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, breast cancer cells overexpressing Ppm1d were sensitive to CCT007093, resulting in decreased cell growth in culture (PMID: 17700519).",
            "molecularProfile": {
                "id": 20201,
                "profileName": "PPM1D over exp"
            },
            "therapy": {
                "id": 3740,
                "therapyName": "CCT007093",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4861,
                    "pubMedId": 17700519,
                    "title": "A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17700519"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5263,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CCT007093 inhibited proliferation of ovarian cancer cell lines overexpressing Ppm1d in culture (PMID: 19293255).",
            "molecularProfile": {
                "id": 20201,
                "profileName": "PPM1D over exp"
            },
            "therapy": {
                "id": 3740,
                "therapyName": "CCT007093",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4973,
                    "pubMedId": 19293255,
                    "title": "PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19293255"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20358,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, FK866 treatment inhibited viability of a transformed cell line overexpressing PPM1D and harboring R458fs in culture (PMID: 31439867).",
            "molecularProfile": {
                "id": 35156,
                "profileName": "PPM1D R458fs PPM1D over exp"
            },
            "therapy": {
                "id": 5662,
                "therapyName": "FK866",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17806,
                    "pubMedId": 31439867,
                    "title": "PPM1D mutations silence NAPRT gene\u00a0expression and confer NAMPT inhibitor sensitivity in glioma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31439867"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20201,
            "profileName": "PPM1D over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35156,
            "profileName": "PPM1D R458fs PPM1D over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}